CINECA IRIS Institutional Research Information System

VIGNANI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.932
EU - Europa 1.885
AS - Asia 1.661
OC - Oceania 125
SA - Sud America 109
AF - Africa 69
Continente sconosciuto - Info sul continente non disponibili 8
Totale 6.789
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.789
CN - Cina 806
IT - Italia 415
JP - Giappone 223
GB - Regno Unito 209
DE - Germania 156
SG - Singapore 127
SE - Svezia 125
FR - Francia 124
IE - Irlanda 124
AU - Australia 116
CA - Canada 110
ES - Italia 106
AT - Austria 102
UA - Ucraina 99
IN - India 90
PL - Polonia 67
KR - Corea 60
TW - Taiwan 57
VN - Vietnam 55
HK - Hong Kong 54
NL - Olanda 46
BR - Brasile 43
FI - Finlandia 43
TR - Turchia 43
GR - Grecia 36
BE - Belgio 35
ID - Indonesia 32
DK - Danimarca 28
PT - Portogallo 28
MX - Messico 25
CH - Svizzera 24
CO - Colombia 23
RU - Federazione Russa 23
IL - Israele 21
CL - Cile 18
TH - Thailandia 17
RO - Romania 16
IR - Iran 15
RS - Serbia 14
NO - Norvegia 13
PH - Filippine 12
ZA - Sudafrica 12
HR - Croazia 11
PK - Pakistan 11
EG - Egitto 10
KE - Kenya 10
LT - Lituania 10
GH - Ghana 9
MA - Marocco 9
NZ - Nuova Zelanda 9
EC - Ecuador 8
EU - Europa 8
IQ - Iraq 8
LB - Libano 8
SK - Slovacchia (Repubblica Slovacca) 8
HU - Ungheria 7
MY - Malesia 6
NG - Nigeria 6
PE - Perù 6
SI - Slovenia 6
AR - Argentina 5
VE - Venezuela 5
CZ - Repubblica Ceca 3
LY - Libia 3
MO - Macao, regione amministrativa speciale della Cina 3
NI - Nicaragua 3
SN - Senegal 3
SY - Repubblica araba siriana 3
BJ - Benin 2
CU - Cuba 2
KZ - Kazakistan 2
LV - Lettonia 2
MT - Malta 2
NE - Niger 2
PR - Porto Rico 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CG - Congo 1
CY - Cipro 1
EE - Estonia 1
GE - Georgia 1
JM - Giamaica 1
JO - Giordania 1
MN - Mongolia 1
PY - Paraguay 1
TN - Tunisia 1
ZM - Zambia 1
Totale 6.789
Salva come PNG Salva come JPEG
Città #
Chandler 232
Redwood City 197
Beijing 195
Fairfield 177
Ashburn 134
Houston 120
Dublin 113
Wilmington 112
Woodbridge 108
Seattle 97
Shanghai 90
Singapore 88
Vienna 88
Tokyo 78
Torino 72
Pisa 70
Nyköping 68
Cambridge 63
Guangzhou 63
Ann Arbor 54
Jacksonville 54
Chengdu 42
Villeurbanne 40
Dong Ket 39
Nanjing 39
Warsaw 39
London 33
Taipei 33
Medford 32
Princeton 31
Duncan 26
Columbus 24
Jakarta 24
Wuhan 23
Boston 21
Binbrook 20
Dearborn 20
New York 20
Athens 19
Changsha 19
Jinan 19
Toronto 19
Chicago 18
Hangzhou 18
Kalundborg 18
Milan 18
Brisbane 17
Raritan 17
Peoria 16
Shenyang 16
Fremont 15
Helsinki 15
San Diego 15
Turin 15
Central District 14
Philadelphia 14
Québec 14
Sydney 14
Santiago 13
Zhengzhou 13
Montréal 12
Paris 12
Bengaluru 11
Berlin 11
Chongqing 11
Kunming 11
Madrid 11
Munich 11
Seoul 11
Belgrade 10
Evanston 10
Istanbul 10
San Francisco 10
São Paulo 10
Tianjin 10
Barcelona 9
Fuzhou 9
Hefei 9
Jerusalem 9
Los Angeles 9
Minneapolis 9
Adelaide 8
Bangkok 8
Bogotá 8
Derby 8
Kolkata 8
Nanchang 8
Ottawa 8
Rome 8
Sewell 8
Valencia 8
Vancouver 8
Bethesda 7
Boardman 7
Bucharest 7
Dallas 7
Gangdong-gu 7
Lanzhou 7
Melbourne 7
Monash 7
Totale 3.494
Salva come PNG Salva come JPEG
Nome #
Addition of docetaxel to androgen deprivation therapy for patients with hormone-sensitive metastatic prostate cancer: A systematic review and meta-analysis 1.178
Understanding and overcoming the mechanisms of primary and acquired resistance to abiraterone and enzalutamide in castration resistant prostate cancer 1.172
Hormonal treatment and quality of life of prostate cancer patients: new evidences 741
Skeletal metastases and impact of anticancer and bone-targeted agents in patients with castration-resistant prostate cancer 511
Molecular biomarkers to predict response to neoadjuvant chemotherapy for bladder cancer 493
Antiandrogen withdrawal syndrome (AAWS) in the treatment of patients with prostate cancer 358
Efficacy of neurokinin-1 receptor antagonists in the prevention of chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based chemotherapy: A systematic review and meta-analysis 322
The fat body mass increase after adjuvant androgen deprivation therapy is predictive of prostate cancer outcome 277
Why castration-resistant prostate cancer patients with neuroendocrine differentiation should be addressed to a cisplatin-based regimen 175
Retrospective study testing next generation sequencing of selected cancer-associated genes in resected prostate cancer 165
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment 150
Immediate or delayed nephrectomy in patients with metastatic renal cancer who are receiving targeted agents: Is the analysis at risk for guarantee- time bias? 137
C28Sequencing cabazitaxel and new generation hormonal treatments in metastatic castration resistant prostate cancer patients after first line docetaxel: a retrospective analysis 135
Enzalutamide-resistant castration-resistant prostate cancer: Challenges and solutions 115
Immunotherapy for patients with advanced urothelial cancer: Current evidence and future perspectives 106
An exploratory analysis of the association between levels of hormones implied in steroid biosynthesis and activity of abiraterone in patients with metastatic castration-resistant prostate cancer 103
Rediscovering secondary tumors of the prostate in the molecular era 100
Prognostic impact of pretreatment neutrophil-to-lymphocyte ratio in castration-resistant prostate cancer patients treated with first-line docetaxel 85
LATITUDE and other coordinates in quality of life of prostate cancer patients 84
Metastatic castration-resistant prostate cancer: Time for innovation 72
Impact of adoption of patient-reported outcomes in clinical practice on the accuracy of symptom reporting in medical records of cancer patients 68
Strategies for managing ACTH dependent mineralocorticoid excess induced by abiraterone. 62
Chemotherapy-Induced Neutropenia and Outcome in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With First-Line Docetaxel 58
Bipolar androgen therapy in prostate cancer: Current evidences and future perspectives 50
Metastatic Renal Medullary Carcinoma Treated With Immune Checkpoint Inhibitor: Case Report and Literature Review 49
Immune-checkpoint inhibitors in previously treated patients with advanced or metastatic urothelial carcinoma: A systematic review and meta-analysis 48
The role of patient-reported outcomes in outpatients receiving active anti-cancer treatment: impact on patients’ quality of life 46
Prognostic role of neuroendocrine differentiation in prostate cancer, putting together the pieces of the puzzle. 38
Prognostic role of early PSa drop in castration resistant prostate cancer patients treated with abiraterone acetate or enzalutamide 33
Evaluation of cognitive function in trials testing new-generation hormonal therapy in patients with prostate cancer: A systematic review 30
Addition of Niraparib to Best Supportive Care as Maintenance Treatment in Patients with Advanced Urothelial Carcinoma Whose Disease Did Not Progress After First-line Platinum-based Chemotherapy: The Meet-URO12 Randomized Phase 2 Trial 19
Gut and local microbiota in patients with cancer: increasing evidence and potential clinical applications 10
TEAM Study: Upfront Docetaxel Treatment in Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Real-World, Multicenter, Retrospective Analysis 8
Totale 6.998
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.947
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.947
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020844 0 0 0 0 69 104 123 115 168 92 80 93
2020/2021996 56 78 74 105 103 85 88 61 73 79 66 128
2021/2022860 68 70 61 62 56 39 68 46 51 85 181 73
2022/2023980 55 105 46 89 98 178 61 68 125 40 76 39
2023/2024745 67 79 44 55 66 89 69 58 20 55 71 72
2024/2025337 49 82 81 95 30 0 0 0 0 0 0 0
Totale 6.998